Literature DB >> 23535058

Use of levonorgestrel intrauterine system for medical indications in adolescents.

Lisa L Bayer1, Paula J Adams Hillard.   

Abstract

The levonorgestrel intrauterine system (LNG-IUS) is an underused contraceptive method in adolescent populations. In addition to being a highly effective, reversible, long-acting contraception, the LNG-IUS has many noncontraceptive health benefits including reduced menstrual bleeding, decreased dysmenorrhea and pelvic pain related to endometriosis, and menstruation suppression in teens with physical or developmental disabilities. The LNG-IUS can also provide endometrial protection in teens with chronic anovulation, and may be used to treat endometrial hyperplasia and cancer. This review examines the evidence supporting the use of the LNG-IUS in adolescents for these noncontraceptive benefits.
Copyright © 2013 Society for Adolescent Health and Medicine. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23535058     DOI: 10.1016/j.jadohealth.2012.09.022

Source DB:  PubMed          Journal:  J Adolesc Health        ISSN: 1054-139X            Impact factor:   5.012


  10 in total

1.  Intrauterine devices at six months: does patient age matter? Results from an urban family medicine federally qualified health center (FQHC) network.

Authors:  Anita Ravi; Linda Prine; Eve Waltermaurer; Natasha Miller; Susan E Rubin
Journal:  J Am Board Fam Med       Date:  2014 Nov-Dec       Impact factor: 2.657

2.  Contraceptive Practices and Reproductive Health Considerations for Adolescent and Adult Women with Intellectual and Developmental Disabilities: A Review of the Literature.

Authors:  Jorge V Verlenden; Jeanne Bertolli; Lee Warner
Journal:  Sex Disabil       Date:  2019-10

3.  Hormone treatment and UVB exposure influences on female mice regarding skin physiological parameters, biochemical parameters and organ histology.

Authors:  Virgiliu Bogdan Şorop; Veronica Mădălina Borugă; Iulia Andreea Pînzaru; Ileana Ramona Barac; Crinela Utescu; Anca Laura Maghiari; Flavia Baderca; Lavinia Bălan; Maria Şorop-Florea; Victor Dumitraşcu; Doru Mihai Anastasiu; Sebastian Simu; Daniela Radu; Oana Suciu
Journal:  Rom J Morphol Embryol       Date:  2020 Jul-Sep       Impact factor: 1.033

4.  Identifying and addressing gaps in reproductive health education for adolescent girls with type 1 diabetes.

Authors:  Jaden R Kohn; Marisa E Hilliard; Sarah K Lyons; Karin A Fox; Jake A Kushner
Journal:  PLoS One       Date:  2018-11-06       Impact factor: 3.240

5.  Painful periods in adolescents.

Authors:  Olga Kciuk; Sari Kives
Journal:  CMAJ       Date:  2021-04-19       Impact factor: 8.262

6.  Utility of the Levonorgestrel-Releasing Intrauterine System in the Treatment of Abnormal Uterine Bleeding and Dysmenorrhea: A Narrative Review.

Authors:  Paola Bianchi; Sun-Wei Guo; Marwan Habiba; Giuseppe Benagiano
Journal:  J Clin Med       Date:  2022-10-01       Impact factor: 4.964

Review 7.  Understanding benefits and addressing misperceptions and barriers to intrauterine device access among populations in the United States.

Authors:  Jennie Yoost
Journal:  Patient Prefer Adherence       Date:  2014-07-03       Impact factor: 2.711

Review 8.  The role of levonorgestrel intrauterine systems in the treatment of symptomatic fibroids.

Authors:  Wojciech Wrona; Anna Stępniak; Piotr Czuczwar
Journal:  Prz Menopauzalny       Date:  2017-12-30

Review 9.  Medical and Behavioral Aspects of Adolescent Endometriosis: A Review of the Literature.

Authors:  Maria-Konstantina Liakopoulou; Ermioni Tsarna; Anna Eleftheriades; Angeliki Arapaki; Konstantina Toutoudaki; Panagiotis Christopoulos
Journal:  Children (Basel)       Date:  2022-03-09

10. 

Authors:  Olga Kciuk; Sari Kives
Journal:  CMAJ       Date:  2021-07-19       Impact factor: 8.262

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.